Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver. (9th November 2013)
- Record Type:
- Journal Article
- Title:
- Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver. (9th November 2013)
- Main Title:
- Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver
- Authors:
- Nahar, Muna S.
Kim, Jung H.
Sartor, Maureen A.
Dolinoy, Dana C.
O'Hagan, Heather
Tang, Winnie - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Alterations in xenobiotic metabolizing enzyme (XME) expression across the life course, along with genetic, nutritional, and environmental regulation, can influence how organisms respond to toxic insults. In this study, we investigated the hypothesis that in utero exposure to the endocrine active compound, bisphenol A (BPA), influences expression and epigenetic regulation of phase I and II XME genes during development. Using healthy 1st to 2nd trimester human fetal liver specimens quantified for internal BPA levels, we examined XME gene expression using PCR Array (<italic>n</italic> = 8) and RNA‐sequencing (<italic>n</italic> = 12) platforms. Of the greater than 160 XME genes assayed, 2 phase I and 12 phase II genes exhibited significantly reduced expression with higher BPA levels, including isoforms from the carboxylesterase, catechol <italic>O</italic>‐methyltransferase, glutathione <italic>S</italic>‐transferase, sulfotransferase, and UDP‐glucuronosyltransferase families. When the promoters of these candidate genes were evaluated <italic>in silico</italic>, putative binding sites for the E‐twenty‐six (ETS) and activator protein1 (AP1) related transcription factor families were identified and unique to 97% of all candidate transcripts. Interestingly, many ETS binding sites contain cytosine‐guanine dinucleotides (CpGs) within their consensus sequences. Thus, quantitative analysis of CpG<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Alterations in xenobiotic metabolizing enzyme (XME) expression across the life course, along with genetic, nutritional, and environmental regulation, can influence how organisms respond to toxic insults. In this study, we investigated the hypothesis that in utero exposure to the endocrine active compound, bisphenol A (BPA), influences expression and epigenetic regulation of phase I and II XME genes during development. Using healthy 1st to 2nd trimester human fetal liver specimens quantified for internal BPA levels, we examined XME gene expression using PCR Array (<italic>n</italic> = 8) and RNA‐sequencing (<italic>n</italic> = 12) platforms. Of the greater than 160 XME genes assayed, 2 phase I and 12 phase II genes exhibited significantly reduced expression with higher BPA levels, including isoforms from the carboxylesterase, catechol <italic>O</italic>‐methyltransferase, glutathione <italic>S</italic>‐transferase, sulfotransferase, and UDP‐glucuronosyltransferase families. When the promoters of these candidate genes were evaluated <italic>in silico</italic>, putative binding sites for the E‐twenty‐six (ETS) and activator protein1 (AP1) related transcription factor families were identified and unique to 97% of all candidate transcripts. Interestingly, many ETS binding sites contain cytosine‐guanine dinucleotides (CpGs) within their consensus sequences. Thus, quantitative analysis of CpG methylation of three candidate genes was conducted across <italic>n</italic> = 50 samples. Higher BPA levels were associated with increased site‐specific methylation at <italic>COMT</italic> (<italic>P</italic> &lt; 0.005) and increased average methylation at <italic>SULT2A1</italic> (<italic>P</italic> &lt; 0.020) promoters. While toxicological studies have traditionally focused on high‐dose effects and hormonal receptor mediated regulation, our findings suggest the importance of low‐dose effects and nonclassical mechanisms of endocrine disruption during development. Environ. Mol. Mutagen. 55:184–195, 2014. © 2013 Wiley Periodicals, Inc.</p> </abstract> … (more)
- Is Part Of:
- Environmental and molecular mutagenesis. Volume 55:Number 3(2014:Apr.)
- Journal:
- Environmental and molecular mutagenesis
- Issue:
- Volume 55:Number 3(2014:Apr.)
- Issue Display:
- Volume 55, Issue 3 (2014)
- Year:
- 2014
- Volume:
- 55
- Issue:
- 3
- Issue Sort Value:
- 2014-0055-0003-0000
- Page Start:
- 184
- Page End:
- 195
- Publication Date:
- 2013-11-09
- Subjects:
- Mutagenesis -- Periodicals
Molecular genetics -- Periodicals
Mutagenèse -- Périodiques
Mutagenèse chimique -- Périodiques
Mutation -- Périodiques
Maladies de l'environnement -- Périodiques
Génétique moléculaire -- Périodiques
576.542 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/em.21823 ↗
- Languages:
- English
- ISSNs:
- 0893-6692
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3791.383100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3383.xml